Keyphrases
Clinical Practice Guidelines
8%
Co-medication
8%
Comorbidity
8%
Conditional Logistic Regression
8%
Cumulative Dose
8%
Epidemiological Study
8%
Fracture Control
8%
Glucocorticoid Use
16%
High Dose
8%
Inverse Variance
8%
Myasthenia Gravis
100%
National Health Service
8%
Non-associated
8%
Odds Ratio
8%
Oral Glucocorticoids
100%
Osteoporosis Prevention
16%
Osteoporotic Fracture Risk
75%
Osteoporotic Fractures
100%
Patient-centered
8%
Pooled Analysis
33%
Population-based
8%
Prolonged Use
8%
Random Effects Model
8%
Variance Method
8%
Medicine and Dentistry
Clinical Guideline
8%
Comorbidity
8%
Drug Megadose
8%
Fragility Fracture
100%
Glucocorticoid
100%
Logistic Regression Analysis
8%
Myasthenia gravis
100%
National Health Service
8%
Odds Ratio
8%
Osteoporosis
16%
Pooled Analysis
33%
Population Research
8%
Random Effects Model
8%
Pharmacology, Toxicology and Pharmaceutical Science
Comorbidity
8%
Fragility Fracture
100%
Glucocorticoid
100%
Myasthenia gravis
100%
Population Study
8%
Random Effects Model
8%
Immunology and Microbiology
Comorbidity
8%
Drug Megadose
8%
Glucocorticoid
100%
Myasthenia gravis
100%
Population Research
8%
Biochemistry, Genetics and Molecular Biology
Comorbidity
9%
Drug Megadose
9%
Glucocorticoid
100%
Population Research
9%